(Q53385157)

13 May 2018

title

Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. (English)

1 reference

13 May 2018

1 reference

4

1 reference

13 May 2018

author name string

Lukas A Hefler

1

1 reference

13 May 2018

Elisabeth Ludwig

2

1 reference

13 May 2018

Antje Lebrecht

3

1 reference

13 May 2018

Dan Tong-Cacsire

5

1 reference

13 May 2018

Heinz Koelbl

6

1 reference

13 May 2018

Sepp Leodolter

7

1 reference

13 May 2018

Clemens B Tempfer

8

1 reference

13 May 2018

publication date

1 November 2002

1 reference

13 May 2018

Journal of the Society for Gynecologic Investigation

published in

1 reference

13 May 2018

volume

9

1 reference

13 May 2018

issue

6

1 reference

13 May 2018

page(s)

386-390

1 reference

13 May 2018

https://api.crossref.org/works/10.1177%2F107155760200900610

1 reference

Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

Phase I trial of escalating doses of interleukin-1 beta in combination with a fixed dose of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

Effects of interleukin-1 alpha on ovarian carcinoma in patients with recurrent disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107155760200900610

10.1177/107155760200900610

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

12445604

1 reference

13 May 2018